Back to Search
Start Over
3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism
3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism
- Source :
- The Journal of Steroid Biochemistry and Molecular Biology. 202:105702
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Bile acids (BAs) are important signaling molecules acting via the farnesoid X nuclear receptor (FXR) and the membrane G protein-coupled bile acid receptor 1 (GPBAR1). Besides deconjugation of BAs, the oxidoreductive enzymes of colonic bacteria and hepatocytes enable the conversion of BAs into their epimers or dehydrogenated forms. Obeticholic acid (OCA) is the first-in-class BA-derived FXR agonist approved for the treatment of primary biliary cholangitis. Herein, a library of OCA derivatives, including 7-keto, 6-ethylidene derivatives and 3β-epimers, was synthetized and investigated in terms of interactions with FXR and GPBAR1 in transaction assays and evaluated for FXR target genes expression in human hepatocytes and C57BL/6 mice. The derivatives were further subjected to cell-free analysis employing in silico molecular docking and a TR-FRET assay. The conversion of the 3βhydroxy epimer and its pharmacokinetics in mice were studied using LC-MS. We found that only the 3β-hydroxy epimer of OCA (3β-isoOCA) possesses significant activity to FXR in hepatic cells and mice. However, in a cell-free assay, 3β-isoOCA had about 9-times lower affinity to FXR than did OCA. We observed that 3β-isoOCA readily epimerizes to OCA in hepatocytes and murine liver. This conversion was significantly inhibited by the hydroxy-Δ5-steroid dehydrogenase inhibitor trilostane. In addition, we found that 3,7-dehydroobeticholic acid is a potent GPBAR1 agonist. We conclude that 3β-isoOCA significantly activates FXR due to its epimerization to the more active OCA by hepatic metabolism. Other modifications as well as epimerization on the C3/C7 positions and the introduction of 6-ethylidene in the CDCA scaffold abrogate FXR agonism and alleviate GPBAR1 activation.
- Subjects :
- Male
0301 basic medicine
Agonist
medicine.drug_class
Endocrinology, Diabetes and Metabolism
Clinical Biochemistry
Receptors, Cytoplasmic and Nuclear
Trilostane
Chenodeoxycholic Acid
Biochemistry
Cell Line
Receptors, G-Protein-Coupled
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
Isomerism
Chlorocebus aethiops
medicine
Animals
Humans
Molecular Biology
Obeticholic acid
Cell Biology
Metabolism
G protein-coupled bile acid receptor
Mice, Inbred C57BL
030104 developmental biology
Liver
chemistry
Nuclear receptor
030220 oncology & carcinogenesis
Molecular Medicine
Farnesoid X receptor
Epimer
medicine.drug
Subjects
Details
- ISSN :
- 09600760
- Volume :
- 202
- Database :
- OpenAIRE
- Journal :
- The Journal of Steroid Biochemistry and Molecular Biology
- Accession number :
- edsair.doi.dedup.....4f9d1aaf9532098d63acb76b04b792eb
- Full Text :
- https://doi.org/10.1016/j.jsbmb.2020.105702